SkinBioTherapeutics Advances with Strategic Acquisitions, Enhancing Revenue
Portfolio | Mar 26, 2025 | EIN
SkinBioTherapeutics, a Newcastle-based life sciences firm, reports improved financial results due to acquisitions and partnerships focused on innovation in skin health. Revenue for the first half of the financial year rose to £1.58 million, while losses narrowed to £1.04 million. The strategic growth included mergers with Dermatonics and Bio-Tech Solutions Ltd, widening expertise and boosting workforce. In collaboration with Croda, SkinBioTherapeutics is set to launch a new SkinBiotix lysate product at a cosmetics show in Amsterdam. The firm, led by CEO Stuart Ashman, emphasizes continuing its acquisition strategy to drive further revenue and profit expansion. With product advancements targeting conditions such as psoriasis and acne, the firm's financial profile is expected to see significant improvements.
Sectors
- Life Sciences
- Cosmetic and Personal Care
Geography
- United Kingdom – SkinBioTherapeutics is based in Newcastle, UK, and operates primarily in this region.
- Netherlands – The product launch will happen in Amsterdam, Netherlands.
Industry
- Life Sciences – The article revolves around a life sciences company specializing in skin health products.
- Cosmetic and Personal Care – SkinBioTherapeutics is launching a new product in the skincare and cosmetics market.
Financials
- £1.58 million – Reported revenue by SkinBioTherapeutics in the first half of the financial year.
- £1.04 million – The narrowed losses of SkinBioTherapeutics for the six months to the end of September.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| SkinBioTherapeutics | Target Company | Company | A life sciences firm focused on skin health, undertaking strategic acquisitions and product development. |
| Croda | Partner | Company | A chemicals firm partnering with SkinBioTherapeutics for product development and launch. |
| Dermatonics | Acquired Company | Company | Acquired by SkinBioTherapeutics to enhance expertise and market presence. |
| Bio-Tech Solutions Ltd (BTS) | Acquired Company | Company | Acquired by SkinBioTherapeutics to boost revenue and serve as a development platform. |
| Umesh Modi Group | Partner | Company | Partnering with SkinBioTherapeutics for sales traction of integrated products. |